À retenir
Among 5888 older adults in the Rotterdam Study, confirmed sarcopenia (HR 1.93) and sarcopenic obesity with 2 altered body composition components (HR 2.84) were associated with the highest all-cause mortality. This is an observational cohort, so the link does not prove that the muscle or fat changes caused the deaths.
Study design
Étude de cohorte
Reading basis
Published abstract
Reading focus
Association & confounding
Cette explication éditoriale existe en anglais, chinois simplifié et chinois traditionnel. Cette interface affiche la lecture en anglais.
Question de recherche
Sarcopenia (low muscle strength and mass) and obesity each harm health in older age, but population data on their combination, sarcopenic obesity (SO), and on mortality were limited. The authors measured how common both are and whether they predict all-cause mortality.
Population et méthode
Population-based cohort from the Rotterdam Study, assessed between March 1, 2009, and June 1, 2014, with mortality from general practitioner and municipal records until October 2022. Probable sarcopenia was low handgrip strength; confirmed sarcopenia and SO added altered body composition (high fat percentage and/or low appendicular skeletal muscle index, by dual-energy x-ray absorptiometry). Kaplan-Meier curves, Cox regression and accelerated failure time models were fitted for sex, age and body mass index (BMI).
Résultats
The authors’ reported results. Read each estimate with its population and uncertainty.
- 1Of 5888 participants (mean age 69.5 years, SD 9.1; mean BMI 27.5, SD 4.3; 3343 [56.8%] female), 653 (11.1%; 95% CI 10.3%-11.9%) had probable sarcopenia and 127 (2.2%; 95% CI 1.8%-2.6%) had confirmed sarcopenia.
- 2SO with 1 altered body composition component was present in 295 participants (5.0%; 95% CI 4.4%-5.6%) and with 2 altered components in 44 (0.8%; 95% CI 0.6%-1.0%).
- 3Mortality risk was higher with probable sarcopenia (HR 1.29, 95% CI 1.14 to 1.47) and confirmed sarcopenia (HR 1.93, 95% CI 1.53 to 2.43).
- 4Compared with people without SO, SO with 1 altered component had HR 1.94 (95% CI 1.60 to 2.33) and with 2 altered components HR 2.84 (95% CI 1.97 to 4.11). Results were similar for participants with a BMI of 27 or greater.
Limites et incertitude
- 1Observational, so illness that causes both weight or muscle loss and death may explain some of the link.
- 2Handgrip strength and body composition were measured once, and the abstract does not say how many deaths occurred or which factors beyond age, sex and BMI were considered.
- 3The Rotterdam Study is a single-region cohort in the Netherlands, so prevalence may differ elsewhere, and the 2 altered component group is small (44 people).
- 4This reading is based on the abstract only.
Mise en perspective
Low grip strength is a simple, useful marker of risk in older age, and the combination with excess body fat appears riskiest. This does not show that building strength would lower the risk, though strength activity is generally encouraged; decisions about care belong with your clinician.
Vos données
Grip strength, body composition and DEXA are clinical measures, but you can track related signals: weight, waist, strength training sessions and some scales' body fat estimates. Smart-scale body fat is only a rough estimate, so compare trends on the same scale under the same conditions.
Comprendre ce type de preuve
Exposure precedes follow-up outcomes, but confounding and reverse causation can remain. A hazard ratio is not an individual absolute risk or a demonstrated intervention effect.
Résumé structuré des auteurs English
Le résumé original en anglais est reproduit avec attribution sous la licence ouverte indiquée. Il s’agit d’une source, pas d’une interprétation MoveVitals. L’analyse préparée figure ci-dessus ; vérifiez les conclusions importantes dans la source.
Importance
Sarcopenia and obesity are 2 global concerns associated with adverse health outcomes in older people. Evidence on the population-based prevalence of the combination of sarcopenia with obesity (sarcopenic obesity [SO]) and its association with mortality are still limited.
Objective
To investigate the prevalence of sarcopenia and SO and their association with all-cause mortality.
Design, setting, and participants
This large-scale, population-based cohort study assessed participants from the Rotterdam Study from March 1, 2009, to June 1, 2014. Associations of sarcopenia and SO with all-cause mortality were studied using Kaplan-Meier curves, Cox proportional hazards regression, and accelerated failure time models fitted for sex, age, and body mass index (BMI). Data analysis was performed from January 1 to April 1, 2023.
Exposures
The prevalence of sarcopenia and SO, measured based on handgrip strength and body composition (BC) (dual-energy x-ray absorptiometry) as recommended by current consensus criteria, with probable sarcopenia defined as having low handgrip strength and confirmed sarcopenia and SO defined as altered BC (high fat percentage and/or low appendicular skeletal muscle index) in addition to low handgrip strength.
Main outcome and measure
The primary outcome was all-cause mortality, collected using linked mortality data from general practitioners and the central municipal records, until October 2022.
Results
In the total population of 5888 participants (mean [SD] age, 69.5 [9.1] years; mean [SD] BMI, 27.5 [4.3]; 3343 [56.8%] female), 653 (11.1%; 95% CI, 10.3%-11.9%) had probable sarcopenia and 127 (2.2%; 95% CI, 1.8%-2.6%) had confirmed sarcopenia. Sarcopenic obesity with 1 altered component of BC was present in 295 participants (5.0%; 95% CI, 4.4%-5.6%) and with 2 altered components in 44 participants (0.8%; 95% CI, 0.6%-1.0%). An increased risk of all-cause mortality was observed in participants with probable sarcopenia (hazard ratio [HR], 1.29; 95% CI, 1.14-1.47) and confirmed sarcopenia (HR, 1.93; 95% CI, 1.53-2.43). Participants with SO plus 1 altered component of BC (HR, 1.94; 95% CI, 1.60-2.33]) or 2 altered components of BC (HR, 2.84; 95% CI, 1.97-4.11) had a higher risk of mortality than those without SO. Similar results for SO were obtained for participants with a BMI of 27 or greater.
Conclusions and relevance
In this study, sarcopenia and SO were found to be prevalent phenotypes in older people and were associated with all-cause mortality. Additional alterations of BC amplified this risk independently of age, sex, and BMI. The use of low muscle strength as a first step of both diagnoses may allow for early identification of individuals at risk for premature mortality.
Sources et attribution
Sarcopenia and Sarcopenic Obesity and Mortality Among Older People.
Benz E, Pinel A, Guillet C, Capel F, Pereira B, De Antonio M, Pouget M, Cruz-Jentoft AJ, Eglseer D, Topinkova E, Barazzoni R, Rivadeneira F, Ikram MA, Steur M, Voortman T, Schoufour JD, Weijs PJM, Boirie Y.
JAMA network open · 2024-03-04
DOI: 10.1001/jamanetworkopen.2024.3604 ↗PubMed · 38526491 ↗Europe PMC · Licence indiquée: cc by ↗Abstract © the original authors, reproduced under the recorded open licence. Translations support reading; use the English record to check terminology and numerical results. Our methodological interpretation is separate from the authors’ conclusions.
Interprétation éditoriale MoveVitals · contenu éducatif · aucune évaluation clinique individuelle enregistrée
Sources vérifiées 2026-11-01
Guides pratiques
À lire ensemble
ACSM review of 137 reviews: resistance training works, and few programme details matter
The American College of Sports Medicine pooled 137 systematic reviews (over 30,000 healthy adults) and concluded that resistance training beats no exercise for strength, muscle size, power, endurance and several function tests. Few programme details changed results consistently: heavier loads (80% or more of one-repetition maximum) and 2 to 3 sets favoured strength, and at least 10 sets a week favoured muscle size, while training to failure, exercise type and periodization did not. It summarises reviews rather than new trials, gives no pooled effect sizes, and drew mostly on untrained adults and overlapping source trials.
Medicine & Science in Sports & Exercise
Nearly every resistance training plan beat no exercise; heavy loads led for strength
In a network meta-analysis of randomised trials in healthy adults (178 studies and 5097 people for strength, 119 studies and 3364 people for muscle size), nearly all resistance training prescriptions beat no exercise. Higher-load, multiset, thrice-weekly training ranked best for strength (standardised mean difference 1.60, 95% credible interval 1.38 to 1.82) and higher-load, multiset, twice-weekly training for muscle size (0.66, 0.47 to 0.85). Most prescriptions could not be statistically separated from each other (the 95% interval contained zero in 91% of the comparisons between them) and risk of bias was moderate to high, so the rankings are tentative.
British Journal of Sports Medicine
Muscle-strengthening linked to lower risk of death, heart disease, cancer and diabetes
Pooling 16 prospective cohort studies of adults, people who did muscle-strengthening activity had a 15% lower risk of all-cause mortality (RR 0.85, 95% CI 0.79 to 0.93) and a 17% lower risk of both cardiovascular disease and diabetes (RR 0.83 for each) than people who did none. The pooled mortality curve was lowest at about 40 min/week (RR 0.83), but whether larger amounts help or hurt is unclear. All of this is observational, from mostly US self-reported data, and the authors rated the certainty of evidence as very low for most outcomes.
British Journal of Sports Medicine
Protein supplements and weight training: small extra gains, smaller in older adults
Pooling 49 randomised trials with 1,863 healthy adults who did resistance training for at least 6 weeks, protein supplements added 0.30 kg of fat-free mass (95% CI 0.09 to 0.52) and 2.49 kg of one-repetition-maximum strength (0.64 to 4.33) on top of training alone. These gains were small next to the effect of training itself, were weaker with older age, and the suggested plateau near 1.6 g/kg/day was not statistically significant (p=0.079). One author has received funding from the US National Dairy Council, which supported trials in the analysis.
British Journal of Sports Medicine

